Trial Profile
Non-inferiority Study of Adjuvanted vs. High Dose Flu Vaccine in Residents of Long Term Care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 26 May 2023 Status changed from active, no longer recruiting to completed.
- 20 May 2022 Planned End Date changed from 30 Sep 2021 to 30 Dec 2022.
- 20 May 2022 Planned primary completion date changed from 30 Sep 2021 to 30 Dec 2022.